Cellanyx is Biotechnology in United States that focus on diagnostic test business. Founded in 2012. They cover business area such as developer, prostate tumor, high-content imaging, machine vision, algorithm, predictive personalized clinical score, metric, personalized diagnostic, therapeutic development, physician, healthcare professional, risk stratification, man, low and intermediate-grade prostate cancer.
2012
( 12 years old in 2024 )
Diagnostic Test
-
100 Cummings Center
Suite 451C
Beverly, MA 01915
United States
Private
developerprostate tumorhigh-content imagingmachine visionalgorithmpredictive personalized clinical scoremetricpersonalized diagnostictherapeutic developmentphysicianhealthcare professionalrisk stratificationmanlow and intermediate-grade prostate cancer
* We use standard office opening hours in near Cellanyx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cellanyx is Biotechnology business from United States that founded in 2012 (12 years old in 2024), Cellanyx business is focusing on Diagnostic Test.
Cellanyx headquarter office and corporate office address is located in 100 Cummings Center Suite 451C Beverly, MA 01915 United States.
Cellanyx was founded in United States.
In 2024, Cellanyx is currently focus on diagnostic test sector.
Above is snippet of Google Trends for "diagnostic test" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cellanyx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
